This document provides information about cancer stages from a presentation by Manipal Hospitals Dwarka, Delhi. It discusses the stages of cancer from in situ to invasive cancer and stages I through IV. Stage 0 is cancer in situ, stage I is a small, non-invasive tumor, stages II and III indicate larger or deeper tumors that may have spread to lymph nodes, and stage IV means the cancer has metastasized. Knowing the cancer stage helps doctors plan treatment and predict outcomes. The document emphasizes the importance of cancer diagnosis and treatment being integrated with early detection and palliative care programs.
Don’t miss our upcoming webinars: Subscribe today!
The CanRehab Team brings together a large group of patients, researchers, and clinicians at four Canadian centres and includes three concurrent projects focused on improving access to effective, appropriate, and timely cancer rehabilitation (CanRehab Team).
The objectives of the presentation are: 1) to provide a background on cancer rehabilitation; 2) to introduce the CanRehab Team projects; and 3) to provide an overview of the team structure including a call for interest to the Patient Advisory Committee.
View the YouTube video: https://youtu.be/B2tcIsrw4WE
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don’t miss our upcoming webinars: Subscribe today!
The CanRehab Team brings together a large group of patients, researchers, and clinicians at four Canadian centres and includes three concurrent projects focused on improving access to effective, appropriate, and timely cancer rehabilitation (CanRehab Team).
The objectives of the presentation are: 1) to provide a background on cancer rehabilitation; 2) to introduce the CanRehab Team projects; and 3) to provide an overview of the team structure including a call for interest to the Patient Advisory Committee.
View the YouTube video: https://youtu.be/B2tcIsrw4WE
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Overview of Guideline and Walk Through SSSL ver 2.0Chea Chan Hooi
A brief review on the principles and rationale behind the latest version of Safe Surgery Saves Lives initiative to enhance patient safety peri-operatively. Delivered in conjunction with a SSSL training workshop, it includes a walk through of the SSSL program.
Cancer Survivorship: longer term issues and the role of primary care - Prof E...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Cancer Survivorship: longer term issues and the role of primary care - Prof Eila Watson (Oxford Brookes University).
Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Join CCSN and Marjut Huotari, VP-Healthcare Insights at Leger, as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey and hear from members of the cancer community about how the pandemic has directly impacted them.
View the video:
https://youtu.be/6ub1ot806-A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
The Long Journey to Personalized Cancer TreatmentsNatasha Tiffany
Award-winning medic Natasha Tiffany, MD, practices at the Oregon Oncology Specialists office in Salem, Oregon. Focused on providing quality medical care to patients with cancer, Natasha Tiffany, MD, recommends immunotherapy treatments.
How We Do Harm: A Webinar by SHARE with Dr. Otis Brawleybkling
Dr. Otis Brawley, author of How We Do Harm, pulls back the curtain on how health care is really practiced in American. Hosted by SHARE: Self-help for Women with Breast or Ovarian Cancer.. www.sharecancersupport.org. If you would like to watch the full webinar, visit www.sharecancersupport.org/brawley.
Don't miss our upcoming webinars: Subscribe today!
In this webinar:
Dr. Paula Gordon will share information on when individuals should start screening for breast cancer, and how often to screen - in order for cancer to be found as early as possible, and to allow the least aggressive options for treatment. Dr. Gordon will also discuss how to screen for recurrence in women who’ve had cancer, explain why these methods are not always offered, and suggest what you can do to improve access to optimal screening.
View the video: https://youtu.be/7uFksz6_4Zk
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
A protocol for the management of breast cancer developed by the multidisciplinary oncology team at University of Nigeria Teaching Hospital, fully adapted to our environment
Overview of Guideline and Walk Through SSSL ver 2.0Chea Chan Hooi
A brief review on the principles and rationale behind the latest version of Safe Surgery Saves Lives initiative to enhance patient safety peri-operatively. Delivered in conjunction with a SSSL training workshop, it includes a walk through of the SSSL program.
Cancer Survivorship: longer term issues and the role of primary care - Prof E...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Cancer Survivorship: longer term issues and the role of primary care - Prof Eila Watson (Oxford Brookes University).
Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Join CCSN and Marjut Huotari, VP-Healthcare Insights at Leger, as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey and hear from members of the cancer community about how the pandemic has directly impacted them.
View the video:
https://youtu.be/6ub1ot806-A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
The Long Journey to Personalized Cancer TreatmentsNatasha Tiffany
Award-winning medic Natasha Tiffany, MD, practices at the Oregon Oncology Specialists office in Salem, Oregon. Focused on providing quality medical care to patients with cancer, Natasha Tiffany, MD, recommends immunotherapy treatments.
How We Do Harm: A Webinar by SHARE with Dr. Otis Brawleybkling
Dr. Otis Brawley, author of How We Do Harm, pulls back the curtain on how health care is really practiced in American. Hosted by SHARE: Self-help for Women with Breast or Ovarian Cancer.. www.sharecancersupport.org. If you would like to watch the full webinar, visit www.sharecancersupport.org/brawley.
Don't miss our upcoming webinars: Subscribe today!
In this webinar:
Dr. Paula Gordon will share information on when individuals should start screening for breast cancer, and how often to screen - in order for cancer to be found as early as possible, and to allow the least aggressive options for treatment. Dr. Gordon will also discuss how to screen for recurrence in women who’ve had cancer, explain why these methods are not always offered, and suggest what you can do to improve access to optimal screening.
View the video: https://youtu.be/7uFksz6_4Zk
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
A protocol for the management of breast cancer developed by the multidisciplinary oncology team at University of Nigeria Teaching Hospital, fully adapted to our environment
Regarding breast cancer diagnoses, almost 80% of cases involve invasive ductal carcinoma. IDC – Invasive (infiltrating) ductal carcinoma begins in a milk passage or duct and breaks through the wall of the duct. Invasive Ductal Breast Cancer generally occurs when the cancer cell invades the basement membrane of the breast, penetrating the underlying supportive tissue. From there, the cells can also extend to other parts of the body.
Lung Cancer Treatment- Manipal Hospitals Delhibhavyamathur0
This presentation is all about Lung Cancer, its types, treatment, symptoms, causes. Manipal Hospitals Dwarka, Delhi is the best cancer hospital in Delhi NCR with the best surgical oncologist. Book an appointment at best cancer surgery Hospital in Delhi NCR
Dr. Pratik Patil is a highly skilled and experienced Medical Oncologist who specialises in
the treatment of breast cancer. He has completed DM Medical Oncology from New Delhi
and is also a Fellow in Thoracic Oncology from Michigan State Cancer University, USA,
and has more than 10 years of experience in treating various types of cancer. He is
associated with reputed medical institutes in India, such as Max Institute of Cancer Care and Sir HN Reliance Hospital, where he has served as a Senior Resident in Medical Oncology.
Looking for a breast cancer specialist in Pune? Dr. Pratik Patil is a breast cancer specialist located in Pune, India. He has extensive experience in the diagnosis, treatment, and management of breast cancer. Dr. Patil is known for his compassionate approach and personalized care for his patients.
Dr. Pk Das Is one of the famous and highly qualified doctor of cancer. He is a cervical cancer specialist in Delhi NCR. Consult Dr.PK Das for all cervical cancer related queries.
Pancreatic cancer ranks as the 12th most prevalent cancer globally. It occupies the 12th position in men and the 11th position among women among the most widespread cancers. Globally, almost 496,000 people are diagnosed with Pancreatic yearly, and around 433,000 die yearly. India is home to several proficient oncologists who have successfully restricted the growth of pancreatic cancer and its symptoms, thus helping people to live a long life. The Pancreatic Cancer Surgery Hospitals in India house one of the most renowned experts in the medical field and, provide the best medical care available.
Pancreatic cancer is a devastating disease that affects thousands of people around the world, and India is no exception. However, in recent years, there have been significant advancements in pancreatic cancer treatment in India, offering new hope to patients and their families. From innovative surgical techniques to targeted therapies and personalized medicine, the journey of courage and healing for pancreatic cancer patients in India has come a long way.
Pancreatic cancer is a devastating disease that affects thousands of people around the world, and India is no exception. However, in recent years, there have been significant advancements in pancreatic cancer treatment in India, offering new hope to patients and their families. From innovative surgical techniques to targeted therapies and personalized medicine, the journey of courage and healing for pancreatic cancer patients in India has come a long way.
Pancreatic cancer is a devastating disease that affects thousands of people around the world, and India is no exception. However, in recent years, there have been significant advancements in pancreatic cancer treatment in India, offering new hope to patients and their families.
Read More: https://gomedii.com/blogs/english/doctors-hospitals/pancreatic-cancer-treatment-in-india/
FINAL-Advocacy-Module 6 Research for advocatesCforCourage
Cancer is a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body.
Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and multiply (through a process called cell division) to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place.
Sometimes this orderly process breaks down, and abnormal or damaged cells grow and multiply when they shouldn’t. These cells may form tumors, which are lumps of tissue. Tumors can be cancerous or not cancerous (benign).
Cancerous tumors spread into, or invade, nearby tissues and can travel to distant places in the body to form new tumors (a process called metastasis). Cancerous tumors may also be called malignant tumors. Many cancers form solid tumors, but cancers of the blood, such as leukemias, generally do not.
Benign tumors do not spread into, or invade, nearby tissues. When removed, benign tumors usually don’t grow back, whereas cancerous tumors sometimes do. Benign tumors can sometimes be quite large, however. Some can cause serious symptoms or be life threatening, such as benign tumors in the brain.
Differences between Cancer Cells and Normal Cells
How Does Cancer Develop?
Types of Genes that Cause Cancer
When Cancer Spreads
Tissue Changes that Are Not Cancer
Types of Cancer
Related Resources
Updated: October 11, 2021
If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “What Is Cancer? was originally published by the National Cancer Institute.”
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
1. A Presentation
On Stages of Cancer
By Manipal Hospitals Dwarka, Delhi
Book Online Appointment or Call us at
01149674967
1
2. Contents
● About Us
● Doctors
● Stages of Cancer
● Cancer Stage
Grouping
● Conclusion
2
3. About Manipal Hospitals Dwarka, Delhi
Manipal Hospitals is one of India’s foremost multi-specialty healthcare providers
catering to both Indian and international patients.
Manipal Hospitals Advantages:
● 75+ Lakhs Live Touched
● 60+ years of Experience
● 2000+ Expert Doctors
● 55+ Specialities
3
4. Our Doctors
Dr. Anusheel Munshi (HOD Radiation Oncology Sciences)
Dr. Vedant Kabra (HOD- Surgical Oncology)
Dr. Bidhu Kalyan Mohanti (Consultant- Radiation Oncology Sciences)
Dr. Peush Bajpai (Senior Consultant- Medical Oncology Sciences)
Dr. Siddharth Kumar Sahai (Consultant- Medical Oncology Sciences)
4
5. Stages of Cancer
● In situ cancer
Early cancer that has not invaded the basement membrane of tissue in which it
developed.
● Invasive cancer
Cancer that has spread beyond the BM and is growing into surrounding healthy
tissues. It is usually divided into 4 stages. TNM (T:Tumour size, L: Lymph node
status and M: Metastasis) is used for breast cancer.
5
6. Staging helps describe where a cancer is located, if or where it has spread, and whether it is
affecting other parts of the body. Doctors often use diagnostic tests to determine a cancer’s
stage. Knowing the stage helps the doctor:
● Plan treatment, including the type of surgery and/or whether chemotherapy or radiation
therapy are needed
● Predict the chance that the cancer will come back after the original treatment
● Predict the chance of recovery
● Talk about the diagnosis in a clear, common language with the entire health care team
● Determine how well the treatment worked
● Compare how well new treatments work among large groups of people with the same
diagnosis
6
7. Cancer stage grouping
Doctors combine the T, N, M results and other factors specific to the cancer to determine the stage of
cancer for each person. Most types of cancer have four stages: stages I (1) to IV (4). Some cancers also
have a stage 0 (zero)
● Stage 0. This stage describes cancer in situ, which means “in place.” Stage 0 cancers are still
located in the place they started and have not spread to nearby tissues. This stage of cancer is
often highly curable, usually by removing the entire tumor with surgery.
● Stage I. This stage is usually a small cancer or tumor that has not grown deeply into nearby
tissues. It also has not spread to the lymph nodes or other parts of the body. It is often called
early-stage cancer.
● Stage II and Stage III. In general, these 2 stages indicate larger cancers or tumors that have
grown more deeply into nearby tissue. They may have also spread to lymph nodes but not to other
parts of the body.
● Stage IV. This stage means that the cancer has spread to other organs or parts of the body. It
may also be called advanced or metastatic cancer. 7
9. 9
Conclusion
Hence the diagnosis and treatment of cancer is a key component of any overall cancer
control plan. Its main goal is to cure cancer patients or prolong their life considerably,
ensuring a good quality of life. In order for a diagnosis and treatment programme to be
effective, it must never be developed in isolation. It needs to be linked to an early detection
programme so that cases are detected at an early stage, when treatment is more effective
and there is a greater chance of cure. It also needs to be integrated with a palliative care
programme, so that patients with advanced cancers, who can no longer benefit from
treatment, will get adequate relief from their physical, psychosocial and spiritual suffering.
Furthermore, programmes should include a awareness-raising component, to educate
patients, family and community members about the cancer risk factors and the need for
taking preventive measures to avoid developing cancer.